* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Asthma Medication

Doctors say 'cool it' when it comes to treating fevers

Parents, do you suffer from . . . fever phobia? Have you ever: • • Awakened a sleeping child to take his or her temperature? • • Chased down a running, giggling but slightly feverish child with a dose of Tylenol? • • Forced a...

Glenmark Pharma Initiates Phase II Trials For Its Molecule Oglemilast

- Glenmark Pharmaceuticals Ltd., a research-driven integrated pharmaceutical company, said it has initiated Phase II study for its lead molecule Oglemilast - GRC 3886 - for the treatment of asthma. The Mumbai-based company said...

Parents' beliefs impact kids' asthma control

NEW YORK (Reuters Health) - Asthma control in over one in three children with asthma is not as good as it could be, and in many cases the suboptimal control relates to potentially modifiable beliefs of the parents, new research...

Icagen Initiates Phase II Proof-of-Concept Trial in Allergic Asthma for Senicapoc Potassium...

RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today the start of a Phase II proof-of-concept clinical trial to evaluate the safety and efficacy of senicapoc, the Company's...

Halotherapy

How Inhaled Salt Can Help Treat Respiratory Conditions The use of halotherapy and salt cave therapy have been shown to be a natural way to help relieve symptoms of respiratory conditions such as asthma and bronchitis. For...

Asthma Drug Linked to Serious Adverse Events

LONDON (MedPage Today) -- For chronic asthma, the regular use of formoterol is associated with a significant increase in non-fatal serious adverse events, according to a systematic review of the literature.

Data Show Aerovance's Aerovant(TM) Inhalation Powder Is Well Tolerated In Asthma Patients

Aerovance Inc. reported pharmacokinetic (PK) and safety data from a Phase I trial of its Aerovant inhalation powder that demonstrate good tolerability with no evidence of local irritancy following asthma patients' inhalation of...

New Data Demonstrates SYMBICORT TURBUHALER SMART Reduces Exacerbations In Asthma Patients And...

New data from the CHAMPION studies presented today at the European Respiratory Society (ERS) congress confirms that Symbicort (budesonide/formoterol) Turbuhaler Maintenance and Reliever Therapy (Symbicort Turbuhaler SMART)...

Asthma Solutions

News Type: Event — Tue Oct 7, 2008 11:24 PM EDT My Asthma Solution The first step you need to take to rid yourself of asthma is to decide TO RID YOURSELF OF THIS DISEASE. Yes, it is a decision. Once you are committed to the...

Dr. Paul Donohue: COPD, 4th leading cause of death

Dear Dr. Donohue: I haven't read anything about chronic obstructive pulmonary disease, COPD, in your column. Will you do something on cause and treatments? Dear V.F.: And I thought I had overdone chronic obstructive pulmonary...

1 2 3 4 5 next »